
Aug 2026 Advisory Council on Alzheimer’s Research, Care, and Services Meeting | August 3, Part 1

During the third meeting of 2026, the Advisory Council will hear from a panel organized by the research subcommittee; updates from federal agencies, including an overview of the authorities of the National Institutes of Health, the Food and Drug Administration, and the Centers for Medicare & Medicaid Services; legislative updates from advocacy groups; and an update on the Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease (REMIND) Study. Advisory Council subcommittees will also present their recommendations for adoption by
the full Advisory Council.
---
U.S. Department of Health and Human Services (HHS)
http://www.hhs.gov
HHS Privacy Policy
Video Summary
AI GeneratedThis meeting of the Advisory Council on Alzheimer's Research, Care, and Services outlines a strategic shift from treating dementia symptoms to preventing the disease. The discussion emphasizes the integration of blood-based biomarkers for early detection, the use of AI to accelerate drug discovery and data analysis, and the implementation of personalized combination therapies.
